PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Positron Mammographic Imaging (PMI)
Sponsor: Case Comprehensive Cancer Center
Listed as NCT01892540, this NA trial focuses on Breast Cancer and Unspecified Adult Solid Tumor, Protocol Specific and remains completed. Sponsored by Case Comprehensive Cancer Center, it has been updated 10 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Apr 2020 — Nov 2020 [monthly]
Completed NA
-
Mar 2020 — Apr 2020 [monthly]
Completed NA
-
Jun 2018 — Mar 2020 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Case Comprehensive Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .